Skip to content

Homeopathy in ringworm

Evaluating feasibility of a double-blind, randomized, placebo-controlled trial of individualized homeopathic medicines in tinea corporis

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031442
Enrollment
34
Registered
2021-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

Intervention1: Individualised homeopathic medicines: It is planned as administering indicated homeopathic remedies in centesimal potencies, as decided appropriate to the case or condition. In centesim
dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP)-certified firm. Route of administration of medicin

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from tinea corporis (2020 ICD-10-CM diagnosis code B35.4) since last 3 months 2. Age 18-65 years 3. Patients of either sex 4. Patient using topical agents for tinea lesions will be included after a washout period of two weeks 5. Patients who are literate and capable of filling the questionnaire and providing written informed consent

Exclusion criteria

Exclusion criteria: 1. Cases with complication like lichenification and eczematisation 2. Similar looking skin conditions; e.g. seborrhic dermatitis, pityriasis rosea and psoriasis 3. Patients who are too sick for consultation 4. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure 5. Pregnant and puerperial women and lactating mothers 6. Substance abuse and/or dependence 7. Self-reported immune-compromised state, and 8. Already undergoing homeopathic treatment for chronic disease within last 6 months.

Design outcomes

Primary

MeasureTime frame
Number of patients in each group showing complete disappearance of the skin lesionsTimepoint: At baseline and after 2 months

Secondary

MeasureTime frame
Intensity of pruritus measured by 0-10 numeric rating scalesTimepoint: At baseline and after 2 months;Skindex-29 scoresTimepoint: At baseline and after 2 months

Countries

India

Contacts

Public ContactProf Dr Shyamal Kumar Mukherjee

D. N. De Homoeopathic Medical College and Hospital

shyamalmukhergee@gmail.com9831113383

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026